{"cluster": 48, "subcluster": 27, "abstract_summ": "METHODS From 1584 COVID-19 patients, 364 severe/critical COVID-19 patients with clinical outcome were enrolled for the final analysis and patients without pre-existing T2DM but elevated glucose levels were excluded.CONCLUSIONS: Our findings suggest that diabetic patients have an increased risk of in-hospital mortality following COVID-19; also, lymphocyte count, creatinine and CRP concentrations could be considered as significant predictors for the death of COVID-19 in these patients.DISCUSSION: Our observational retrospective case series shows that diabetic patients are at risk of developing combined DKA/ HHS associated with COVID-19 and a substantial mortality.In this study, we compared the outcome of metformin users and nonusers in hospitalized COVID-19 patients with diabetes.CONCLUSION: We firstly showed that COVID\u201019 patients with newly diagnosed diabetes had the highest risk of all\u2010cause mortality compared with COVID\u201019 patients with known diabetes, hyperglycemia and normal glucose.", "title_summ": "Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19.The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single centerPrognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reportsObservational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative ReviewAssociation of the insulin resistance marker TyG index with the severity and mortality of COVID-19Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 DiabetesWell-controlled vs Poorly-controlled Diabetes in Patients with COVID-19: Are There Any Differences in Outcomes and Imaging Findings?Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular diseaseDoes poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID\u201019Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case SeriesImpact of diabetes mellitus on clinical outcomes in patients affected by Covid-19Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis.States.[The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the UnitedMetabolic syndrome and its components in adult hypopituitary patients.", "title_abstract_phrases": "Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.CONCLUSION Among hospitalized patients with COVID-19, diabetes and/or uncontrolled hyperglycemia occurred frequently.METHODS From 1584 COVID-19 patients, 364 severe/critical COVID-19 patients with clinical outcome were enrolled for the final analysis and patients without pre-existing T2DM but elevated glucose levels were excluded.CONCLUSIONS: Our findings suggest that diabetic patients have an increased risk of in-hospital mortality following COVID-19; also, lymphocyte count, creatinine and CRP concentrations could be considered as significant predictors for the death of COVID-19 in these patients.DISCUSSION: Our observational retrospective case series shows that diabetic patients are at risk of developing combined DKA/ HHS associated with COVID-19 and a substantial mortality."}